July 14, 2022
Mochida Pharmaceutical has decided to discontinue sales of its biosimilar version of the G-CSF preparation filgrastim, Jiho learned on July 13. According to a company official, this decision stems from “an issue related to sales, not manufacturing.” The drug maker...read more